Lentiviral-mediated Overexpression of Bcl-xL Protects Primary Endothelial Cells From Ischemia/Reperfusion Injury-induced Apoptosis

Journal of Heart and Lung Transplantation

Volumn 28, Issue 9, 2009, Pages 936-943

  Zhao, Jing ^a   Bolton, Eleanor Mary ^a   Bradley, John Andrew ^a   Lever, Andrew Michael Lindsay ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; LENTIVIRUS VECTOR; PLASMID DNA; PROTEIN BAX; PROTEIN BCL XL;

ANIMAL CELL; AORTA; APOPTOSIS; ARTICLE; CELL DEATH; CHRONIC ALLOGRAFT VASCULOPATHY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ASSAY; GENETIC TRANSDUCTION; HYPOXIA; INFLAMMATION; ISCHEMIA; KIDNEY TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; ANOXIA; AORTA; APOPTOSIS; BCL-X PROTEIN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GENE DELETION; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; PLASMIDS; RATS; REPERFUSION INJURY; TRANSFECTION; VIRAL PROTEINS;

EID: 68949219479     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.05.014     Document Type: Article

References (55)

1. Pober J.S., Doukas J., Hughes C.C., et al. The potential roles of vascular endothelium in immune reactions. Hum Immunol 28 (1990) 258-262
2. Bach F.H., Ferran C., Hechenleitner P., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196-204
3. Badrichani A.Z., Stroka D.M., Bilbao G., et al. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest 103 (1999) 543-553
4. Ferran C. Protective genes in the vessel wall: modulators of graft survival and function. Transplantation 82 suppl (2006) S36-S40
5. Cailhier J.F., Laplante P., and Hebert M.J. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transplant 6 (2006) 247-253
6. Vassalli G., Gallino A., Weis M., et al. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 24 (2003) 1180-1188
7. Cecka J.M. The UNOS Scientific Renal Transplant Registry-2000. Clin Transplant (2000) 1-18
8. Gjertson D.W., and Cecka J.M. Living unrelated donor kidney transplantation. Kidney Int 58 (2000) 491-499
9. Terasaki P.I., Cecka J.M., Gjertson D.W., et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333 (1995) 333-336
10. Bach F.H., Hancock W.W., and Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 18 (1997) 483-486
11. Hancock W.W., Buelow R., Sayegh M.H., et al. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4 (1998) 1392-1396
12. Kunter U., Floege J., von Jurgensonn A.S., et al. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation 75 (2003) 3-9
13. Daniel S., Arvelo M.B., Patel V.I., et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104 (2004) 2376-2384
14. Vassalli G., Fleury S., Li J., et al. Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection. Eur J Cardiothorac Surg 24 (2003) 794-806
15. Brocheriou V., Hagege A.A., Oubenaissa A., et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2 (2000) 326-333
16. Cefai D., Simeoni E., Ludunge K.M., et al. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo. J Mol Cell Cardiol 38 (2005) 333-344
17. Bilbao G., Contreras J.L., Eckhoff D.E., et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 230 (1999) 185-193
18. Kirshenbaum L.A., and de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96 (1997) 1580-1585
19. Chen Z., Chua C.C., Ho Y.S., et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 280 (2001) H2313-H2320
20. Chien C.T., Chen C.F., Hsu S.M., et al. Protective mechanism of preconditioning hypoxia attenuates apoptosis formation during renal ischemia/reperfusion phase. Transplant Proc 31 (1999) 2012-2013
21. Schwarz C., Hauser P., Steininger R., et al. Failure of BCL-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest 82 (2002) 941-948
22. Zhao J., and Lever A.M. Lentivirus-mediated gene expression. Methods Mol Biol 366 (2007) 343-355
23. Zhao J., Pettigrew G.J., Bolton E.M., et al. Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection. Gene Ther 12 (2005) 1509-1516
24. Zhao J., Renner O., Wightman L., et al. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem 273 (1998) 23072-23079
25. Knight R.J., Dikman S., Liu H., et al. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 64 (1997) 1102-1107
26. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643-654
27. Hebert M.J., Gullans S.R., Mackenzie H.S., et al. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop. Am J Pathol 152 (1998) 523-532
28. 2, and PAF. J Clin Invest 101 (1998) 890-898
29. Johnson N.A., Sengupta S., Saidi S.A., et al. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J 18 (2004) 188-190
30. Shi Y., Fard A., Vermani P., et al. Transgene expression in the coronary circulation: transcatheter gene delivery. Gene Ther 1 (1994) 408-414
31. Tanner F.C., Carr D.P., Nabel G.J., et al. Transfection of human endothelial cells. Cardiovasc Res 35 (1997) 522-528
32. Schulick A.H., Newman K.D., Virmani R., et al. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 91 (1995) 2407-2414
33. Dishart K.L., Denby L., George S.J., et al. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J Mol Cell Cardiol 35 (2003) 739-748
34. Sakoda T., Kasahara N., Kedes L., et al. Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors. Prep Biochem Biotechnol 37 (2007) 1-11
35. Lever A.M., Strappe P.M., and Zhao J. Lentiviral vectors. J Biomed Sci 11 (2004) 439-449
36. Mok H.P., Javed S., and Lever A. Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther 14 (2007) 741-751
37. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
38. Baumgartner-Parzer S.M., Wagner L., Pettermann M., et al. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44 (1995) 1323-1327
39. Grafe M., Auch-Schwelk W., Hertel H., et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 137 (1998) 87-95
40. Rafii S., Dias S., Meeus S., et al. Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression. Circ Res 88 (2001) 903-910
41. Tan P.H., Xue S.A., Manunta M., et al. Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol 26 (2006) 462-467
42. Duchen M.R. Roles of mitochondria in health and disease. Diabetes 53 suppl 1 (2004) S96-S102
43. Kumar S., Kasseckert S., Kostin S., et al. Ischemic acidosis causes apoptosis in coronary endothelial cells through activation of caspase-12. Cardiovasc Res 73 (2007) 172-180
44. Ferrari R., Cargnoni A., Bernocchi P., et al. Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation 94 (1996) 2587-2596
45. Terminella C., Tollefson K., Kroczynski J., et al. Inhibition of apoptosis in pulmonary endothelial cells by altered pH, mitochondrial function, and ATP supply. Am J Physiol Lung Cell Mol Physiol 283 (2002) L1291-L1302
46. Cutaia M., Tollefson K., Kroczynski J., et al. Role of the Na/H antiport in pH-dependent cell death in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 278 (2000) L536-L544
47. Wolf C.M., Reynolds J.E., Morana S.J., et al. The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. Exp Cell Res 230 (1997) 22-27
48. Azizian M., Ramenaden E.R., Shah G., et al. Augmentation of ischemia/reperfusion injury to endothelial cells by cyclosporin A. Am Surg 70 (2004) 438-442
49. Kohli V., Selzner M., Madden J.F., et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67 (1999) 1099-1105
50. Ballinger S.W., Patterson C., Knight-Lozano C.A., et al. Mitochondrial integrity and function in atherogenesis. Circulation 106 (2002) 544-549
51. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
52. Ballinger S.W., Patterson C., Yan C.N., et al. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86 (2000) 960-966
53. Finsterer J. Is atherosclerosis a mitochondrial disorder?. Vasa 36 (2007) 229-240
54. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
55. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316